Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies.
Chan A, Cameron MC, Garden B, Boers-Doets CB, Schindler K, Epstein JB, Choi J, Beamer L, Roeland E, Russi EG, Bensadoun RJ, Teo YL, Chan RJ, Shih V, Bryce J, Raber-Durlacher J, Gerber PA, Freytes CO, Rapoport B, LeBoeuf N, Sibaud V, Lacouture ME. Chan A, et al. Among authors: epstein jb. Support Care Cancer. 2015 Aug;23(8):2231-44. doi: 10.1007/s00520-014-2564-x. Epub 2015 Jan 7. Support Care Cancer. 2015. PMID: 25564221 Free PMC article. Review.
Periodontal infection in cancer patients treated with high-dose chemotherapy.
Raber-Durlacher JE, Epstein JB, Raber J, van Dissel JT, van Winkelhoff AJ, Guiot HF, van der Velden U. Raber-Durlacher JE, et al. Among authors: epstein jb. Support Care Cancer. 2002 Sep;10(6):466-73. doi: 10.1007/s00520-002-0346-3. Epub 2002 Mar 23. Support Care Cancer. 2002. PMID: 12353125 Review.
Updated clinical practice guidelines for the prevention and treatment of mucositis.
Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE; Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology. Keefe DM, et al. Among authors: epstein jb. Cancer. 2007 Mar 1;109(5):820-31. doi: 10.1002/cncr.22484. Cancer. 2007. PMID: 17236223 Free article.
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group.
Lacouture ME, Maitland ML, Segaert S, Setser A, Baran R, Fox LP, Epstein JB, Barasch A, Einhorn L, Wagner L, West DP, Rapoport BL, Kris MG, Basch E, Eaby B, Kurtin S, Olsen EA, Chen A, Dancey JE, Trotti A. Lacouture ME, et al. Among authors: epstein jb. Support Care Cancer. 2010 Apr;18(4):509-22. doi: 10.1007/s00520-009-0744-x. Epub 2010 Feb 10. Support Care Cancer. 2010. PMID: 20145956
A systematic review of orofacial pain in patients receiving cancer therapy.
Epstein JB, Hong C, Logan RM, Barasch A, Gordon SM, Oberle-Edwards L, McGuire D, Napenas JJ, Elting LS, Spijkervet FK, Brennan MT. Epstein JB, et al. Support Care Cancer. 2010 Aug;18(8):1023-31. doi: 10.1007/s00520-010-0897-7. Epub 2010 Jun 11. Support Care Cancer. 2010. PMID: 20544225 Review.
The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial.
Elad S, Epstein JB, Raber-Durlacher J, Donnelly P, Strahilevitz J. Elad S, et al. Among authors: epstein jb. J Oral Pathol Med. 2012 Mar;41(3):229-34. doi: 10.1111/j.1600-0714.2011.01094.x. Epub 2011 Nov 14. J Oral Pathol Med. 2012. PMID: 22077420 Clinical Trial.
481 results